ABRAM Therapeutics Limited

ABRAM Therapeutic Limited is a biopharma spinout from the universities, with the mission to use our patented technology to treat obesity and obesity-related metabolic diseases using the first-in-class long-acting drug ABarginase. ABarginase was invented via smart drug design and protein engineering, and has shown potent anti-obesity and insulin-sensitizing effects in preclinical studies. We will conduct further R&D to bring ABarginase from bench to bedside, with an aim to bring a paradigm shift in obesity and related metabolic diseases treatment to address the unmet medical needs.

Team Member(s)
Prof. LEUNG Yun Chung Thomas (Department of Applied Biology and Chemical Technology)

Prof. SHUM Sau Wun Alisa

Dr. KWOK Sui Yi Christine